ESSA Pharma (NASDAQ:EPIX) Share Price Crosses Below 50-Day Moving Average – Should You Sell?

ESSA Pharma Inc. (NASDAQ:EPIX) (TSE:EPI) crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $1.68 and traded as low as $1.55. ESSA Pharma shares last traded at $1.55, with a volume of 82,165 shares.

ESSA Pharma Price Performance

The company’s fifty day moving average price is $1.68 and its 200 day moving average price is $2.89. The company has a market cap of $68.36 million, a PE ratio of -2.23 and a beta of 1.59.

ESSA Pharma (NASDAQ:EPIX) (TSE:EPI) last issued its quarterly earnings data on Tuesday, February 11th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.01). On average, analysts forecast that ESSA Pharma Inc. will post -0.42 EPS for the current year.

Institutional Trading of ESSA Pharma

A number of hedge funds have recently bought and sold shares of EPIX. Squarepoint Ops LLC purchased a new stake in shares of ESSA Pharma during the 4th quarter valued at $26,000. Two Sigma Securities LLC purchased a new stake in ESSA Pharma during the fourth quarter worth about $29,000. GTS Securities LLC purchased a new stake in ESSA Pharma during the fourth quarter worth about $30,000. FNY Investment Advisers LLC bought a new stake in ESSA Pharma in the fourth quarter worth about $44,000. Finally, Cubist Systematic Strategies LLC purchased a new position in ESSA Pharma in the fourth quarter valued at about $47,000. 75.12% of the stock is currently owned by institutional investors.

ESSA Pharma Company Profile

ESSA Pharma Inc, a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company’s lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer.